FT
PLRX icon

Fiduciary Trust’s Pliant Therapeutics PLRX Stock Holding History

Fiduciary Trust’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6K Hold
11,620
– – ﹤0.01% 865
2025
Q4 		$14.2K Hold
11,620
– – ﹤0.01% 857
2025
Q3 		$17.2K Hold
11,620
– – ﹤0.01% 846
2025
Q2 		$13.5K Hold
11,620
– – ﹤0.01% 827
2025
Q1 		$15.7K Hold
11,620
– – ﹤0.01% 816
2024
Q4 		$153K Hold
11,620
– – ﹤0.01% 672
2024
Q3 		$130K Hold
11,620
– – ﹤0.01% 643
2024
Q2 		$125K Hold
11,620
– – ﹤0.01% 615
2024
Q1 		$173K Hold
11,620
– – ﹤0.01% 625
2023
Q4 		$210K Hold
11,620
– – ﹤0.01% 599
2023
Q3 		$201K Hold
11,620
– – ﹤0.01% 592
2023
Q2 		$211K Buy
11,620
+3,620
+45% +$85.7K ﹤0.01% 600
2023
Q1 		$213K Sell
8,000
-2,711
-25% -$77.2K ﹤0.01% 588
2022
Q4 		$207K Buy
+10,711
New +$224K ﹤0.01% 597

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return